VivoSeq
Other

Embryo Transfer

0

Pipeline Programs

6

Active Trials

1

Companies Involved

Embryo Transfer is an early-stage landscape with 0 programs across 1 company. The most active players are Premium Fertility.

Pipeline Metrics

Competitive Density

21/100

Pipeline Velocity

15/100

Mech. Concentration

N/A

Completion Rate

89/100

Attrition Rate

4/100

Competitive Landscape

Bubble size = clinical trials

Approved
Phase 3
Phase 2
Phase 1
Preclinical

Top Companies Companies ranked by the number of pipeline programs they run for this disease.

Programs by Phase

No pipeline programs currently tracked for this disease.

Trial Status

48

clinical trials

Completed24 · 50%
Unknown status15 · 31%
Recruiting4 · 8%
Not yet recruiting2 · 4%
Suspended1 · 2%
Terminated1 · 2%
Other1 · 2%

Trial Activity

48 trials

The Role of hCG in Thawed Embryo Transfer
Recruiting·FFertility Center of Las Vegas·Phase 4·NCT07004192·220 enrolled
Ketorolac Use and Fresh Embryo Transfer Outcomes
Recruiting··Phase 4·NCT07185724·200 enrolled
Assessment of Transfer Direct System (TDS) as a New Method for Embryo Transfer
Recruiting··Preclinical·NCT06744049·80 enrolled
Frozen-thawed Embryo Transfer (FTET) Cycle Follow-up Protocol (P06031)
Completed··Phase 3·NCT01146418·307 enrolled
Endometrial Priming for Embryo Transfer
Completed·PParc de Salut Mar·Phase 4·NCT01430650·140 enrolled
Page 1 of 4

Data sources: ClinicalTrials.gov (NIH) · OpenFDA (FDA) · ChEMBL (EMBL-EBI) · Open Targets (EBI/Sanger) · MedlinePlus (NIH) · PubMed (NIH) · SEC EDGAR (SEC)